These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12190205)

  • 1. Road traffic accident as an iatrogenic complication of steroid treatment in Crohn's disease.
    Jacob R; Walsh C; Hunter JO
    Am J Gastroenterol; 2002 Aug; 97(8):2154-5. PubMed ID: 12190205
    [No Abstract]   [Full Text] [Related]  

  • 2. Prednisolone in the management of patients with Crohn's disease.
    Cronin E
    Br J Nurs; 2010 Nov 25-Dec 8; 19(21):1333-6. PubMed ID: 21355357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
    Tobias JH; Sasi MR; Greenwood R; Probert CS
    Aliment Pharmacol Ther; 2004 Nov; 20(9):951-7. PubMed ID: 15521842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatitis caused by Solupred in a patient with Crohn disease].
    Gerolami R; Mambrini P; Barthet M; Jean-Pastor MJ; Salducci J; Grimaud JC
    Gastroenterol Clin Biol; 1997; 21(3):236-7. PubMed ID: 9161506
    [No Abstract]   [Full Text] [Related]  

  • 5. Esophagitis in an adolescent patient with Crohn's disease after changing treatment from prednisolone to budesonide.
    Weigand K; Wagner-Thiessen E; Stolte M
    Z Gastroenterol; 2004 Oct; 42(10):1179-81. PubMed ID: 15508059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
    Herrlinger KR; Witthoeft T; Raedler A; Bokemeyer B; Krummenerl T; Schulzke JD; Boerner N; Kueppers B; Emmrich J; Mescheder A; Schwertschlag U; Shapiro M; Stange EF
    Am J Gastroenterol; 2006 Apr; 101(4):793-7. PubMed ID: 16635225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methotrexate-induced pneumonitis in a woman with Crohn's disease].
    Brechmann T; Heyer C; Schmiegel W
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1759-62. PubMed ID: 17713885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
    Abreu MT
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):210-1. PubMed ID: 16265201
    [No Abstract]   [Full Text] [Related]  

  • 9. Gallbladder perforation in a patient on steroid therapy.
    Andrabi SI; Ahmad J; Rathore MA; El-Hakeem AA
    N Z Med J; 2007 Aug; 120(1260):U2686. PubMed ID: 17726500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A successful switch from prednisone to budesonide for neuropsychiatric adverse effects in a patient with ileal Crohn's disease.
    Nahon S; Pisanté L; Delas N
    Am J Gastroenterol; 2001 Jun; 96(6):1953-4. PubMed ID: 11419871
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine.
    Lee FL; Murray SM; Prior J; Shreeve DR
    Hepatogastroenterology; 1983 Oct; 30(5):188. PubMed ID: 6315555
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid induced atrial fibrillation.
    Iqbal FM; Beeharilal PS; Sadat K; Mohajer R; Lewis BE
    Compr Ther; 2008; 34(2):111-4. PubMed ID: 18833788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancreatitis associated with corticosteroid treatment in Crohn's disease].
    Boruchowicz A; Gallon P; Foissey D; Gower P; Gamblin C; Cuingnet P; Maunoury V; Cortot A; Colombel JF
    Gastroenterol Clin Biol; 2003 May; 27(5):560-1. PubMed ID: 12843925
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid dependency in Crohn's disease.
    Reinisch W; Vogelsang H
    Gastroenterology; 2002 Jul; 123(1):393-5; author reply 395. PubMed ID: 12105883
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corticodependent Crohn's disease].
    Lerebours E; Savoye G
    Gastroenterol Clin Biol; 2004 May; 28(5 Suppl):D194-201. PubMed ID: 15213680
    [No Abstract]   [Full Text] [Related]  

  • 19. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
    Nielsen AA; Jørgensen LG; Nielsen JN; Eivindson M; Grønbaek H; Vind I; Hougaard DM; Skogstrand K; Jensen S; Munkholm P; Brandslund I; Hey H
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1121-8. PubMed ID: 16305726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone.
    Nielsen AA; Nielsen JN; Grønbaek H; Eivindson M; Vind I; Munkholm P; Brandslund I; Hey H
    Digestion; 2007; 75(1):10-6. PubMed ID: 17429201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.